Literature DB >> 28579442

Phosphaturic mesenchymal tumor of the nasal cavity and paranasal sinuses: A clinical curiosity presenting a diagnostic challenge.

Shubhada V Kane1, Aanchal Kakkar2, Nikita Oza1, Epari Sridhar1, Prathamesh S Pai3.   

Abstract

Phosphaturic mesenchymal tumor (PMT) is a rare mesenchymal neoplasm associated with tumor-induced osteomalacia (TIO) and elevated serum FGF-23. Common in extremities, PMT rarely occurs in sinonasal region. We report a series of sinonasal PMT diagnosed at our institute over a 6-year period. Six cases of sinonasal PMT were identified during this period, of which five presented with features of TIO. Median age of patients was 45.5 years. All six tumors were composed of stellate to spindled cells, with prominent staghorn vasculature in four cases. Typical smudgy matrix was seen in all cases, but only focally; grungy calcification was absent. Accurate diagnosis of PMTs is imperative, as complete excision leads to dramatic resolution of TIO symptoms. Lack of knowledge of this entity prevents clinicians from ordering relevant investigations. Absence of specific morphological features, like grungy calcification, and presentation at atypical locations makes the diagnosis challenging. Awareness of this entity is essential in order to suspect PMT in patients presenting with a soft tissue mass and features of TIO, however unusual the location may be.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FGF-23; Phosphaturic mesenchymal tumor; Sinonasal; Tumor-induced osteomalacia

Mesh:

Year:  2017        PMID: 28579442     DOI: 10.1016/j.anl.2017.05.006

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  8 in total

Review 1.  Tumor-Induced Osteomalacia.

Authors:  Pablo Florenzano; Iris R Hartley; Macarena Jimenez; Kelly Roszko; Rachel I Gafni; Michael T Collins
Journal:  Calcif Tissue Int       Date:  2020-06-05       Impact factor: 4.333

2.  Varied presentation of sinonasal phosphaturic mesenchymal tumour: report of a case series with follow-up.

Authors:  Regi Kurien; Vedantam Rupa; Meera Thomas
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-16       Impact factor: 2.503

Review 3.  Metastatic Malignant Phosphaturic Mesenchymal Tumor of Mandibular Alveolus: a Rare Case Report and Review of Literature.

Authors:  Kuldeep Thakur; Chirom Amit Singh; Aanchal Kakkar; Rakesh Kumar; Atul Sharma; Alok Thakar
Journal:  Indian J Surg Oncol       Date:  2021-09-22

4.  Phosphaturic Mesenchymal Tumor.

Authors:  J C Benson; J A Trejo-Lopez; A M Nassiri; K Eschbacher; M J Link; C L Driscoll; R D Tiegs; J Sfeir; D R DeLone
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

5.  Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.

Authors:  Xiang Li; Yan Jiang; Li Huo; Huanwen Wu; Yong Liu; Jin Jin; Wei Yu; Wei Lv; Lian Zhou; Yu Xia; Ou Wang; Mei Li; Xiaoping Xing; Yue Chi; Ruizhi Jiajue; Lijia Cui; Xunwu Meng; Weibo Xia
Journal:  J Bone Miner Res       Date:  2019-11-15       Impact factor: 6.741

6.  A Pictorial Essay of Somatostatin Receptor Imaging in Tumor-Induced Osteomalacia: A Single Institutional Experience.

Authors:  Karuna Luthra; Dinesh Kumar Gauthaman; Vikram Lele
Journal:  Indian J Nucl Med       Date:  2022-03-25

Review 7.  Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.

Authors:  Deepika Mishra; Harpreet Kaur; Ashu Seith Bhalla; Smita Manchanda; Jithin Sasikumar; Bhaskar Agarwal; Ajoy Roychoudhury
Journal:  Head Neck Pathol       Date:  2021-01-04

8.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.